MAPT and Alzheimer disease: In AD, pathological analysis, clinical analysis and biomarker data indicate that following accumulation of a high β-amyloid load in isocortical regions, Tau-pathology is propagated beyond EC/LC in a more aggressive way and with associated symptoms [3, 4, 19, 25, 26, 31, 46, 47, 53, 54].